Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Molecular Cancer|January 14, 2018
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumorsErhao Zhang, Jieyi Gu, Hanmei XuVirology Journal|November 8, 2024
Pilot-scale process development for recombinant adeno-associated virus (rAAV) production based on high-density Sf9 cell cultureXinran Li, Jieyi Gu, Haoquan Wu, et al.Current Pharmaceutical Biotechnology|January 24, 2025
A Fed-batch Process for the Production of Recombinant Adeno-Associated Virus (rAAV) Vectors Using the Sf9-Rhabdovirus-Negative Cell LineXinran Li, Jieyi Gu, Haoquan Wu, et al.Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|June 24, 2023
Comparative transcriptome analysis of gonads in male and female Pseudobagrus ussuriensis (Bagridae, Siluriformes)Long Wang, Tianyu Guan, Jieyi Gu, et al.Aquatic Toxicology (Amsterdam, Netherlands)|July 9, 2023
Effects of copper on gill function of juvenile oriental river prawn (Macrobrachium nipponense): Stress and toxic mechanismLong Wang, Tianyu Guan, Guiling Wang, et al.Molecular Diversity|December 31, 2009
Predicting miRNA's target from primary structure by the nearest neighbor algorithmKao Lin, Ziliang Qian, Lin Lu, et al.Cancer Medicine|June 26, 2019
Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12Xiaowei Chi, Peiwei Yang, Erhao Zhang, et al.Journal of Hematology & Oncology|March 22, 2018
Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptideErhao Zhang, Jieyi Gu, Jianpeng Xue, et al.Journal of Hematology & Oncology|August 15, 2018
Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancyErhao Zhang, Peiwei Yang, Jieyi Gu, et al.Pageof 1